Thats why this blog existsto help take some of that guesswork off your plate
A patient starting at 120 mg/dL might see only a 12 to 15 mg/dL decline
Some stretch the period from seven days, initially to ten, then slowly increase the period, lowering their dependence on the GLP-1 medication
August 9th, 2025: Lawsuits Mount Over Vision Loss Risks Linked to Ozempic, Wegovy, and Mounjaro New research has suggested a possible connection between GLP-1 receptor agonist drugsincluding Ozempic, Wegovy, and Mounjaroand heightened risks of severe eye conditions such as neovascular age-related macular degeneration (nAMD) and nonarteritic anterior ischemic optic neuropathy (NAION)
Among adults without type 2 diabetes, a direct comparison between tirzepatide and semaglutide showed that tirzepatide was associated with higher hazards of anxiety disorders and insomnia than semaglutide, while no consistent differences were observed for most neurological outcomes after statistical adjustment